Drug discovery began as a serendipitous, trial-and-error effort. Montai is pioneering a new era of predictable discovery for small molecule medicines that would not have been possible even a few years ago. Fueled by the exponential growth in biochemical data over the last decade and far more powerful computational tools, we are decoding the complex language of chemistry computationally, generating deep understanding of the structure-function relationships in any molecule to efficiently predict its potential to become a drug.

When we apply these powerful tools to aggregate and then survey the landscape of Anthromolecule chemistry, we can predictably and hyper-efficiently find and validate the best possible keys to unlock any biology pathway door.

Montai is aggregating and curating the world's largest, fully-annotated library of Anthromolecule chemistry - bioactive molecules humans have chronically consumed in foods, supplements, and herbal medicines. The 125,000+ bioactive Anthromolecules in our library today offer 2-3 times greater chemical diversity and scaffolds than standard synthetic chemistry libraries.

Anthromolecule chemistry is a proven source of chronically-dosed, FDA-approved drugs for many diseases, but has yet to be systematically and predictably mined for drug development.

Anthromolecules have co-evolved in humans over millennia, interacting with our own biology to maintain health. More than 85% of Anthromolecules are structurally unique versus synthetic libraries most drug development focuses on today, presenting a far greater variety of building blocks for engaging disease pathways that have eluded traditional medicinal chemistry approaches. Montai’s AI tools unlock precision connections between this diverse chemistry and the known drivers of complex disease biology presenting entirely new ways to treat diseases with a pill.